AVIE - ETF AI Analysis
Top Page
Avantis Inflation Focused Equity ETF (AVIE)
Rating:71Outperform
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating positive momentum.
Inflation-Resilient Sector Mix
Heavy exposure to energy, health care, and consumer defensive companies can help the fund hold up better when inflation is elevated.
Reasonable Expense Ratio
The fund’s fee is moderate for an actively managed, specialized equity ETF, allowing investors to keep more of their returns.
Negative Factors
Very Small Fund Size
With relatively low assets under management, the ETF may face higher trading spreads and a greater risk of closure than larger funds.
High U.S. Concentration
Almost all of the portfolio is invested in U.S. stocks, offering little geographic diversification.
Mixed Performance Among Top Holdings
Some of the largest positions, including major financial and health care names, have recently lagged, which can drag on overall returns.
AVIE vs. SPDR S&P 500 ETF (SPY)
AUM10.58M
RegionNorth America
Expense Ratio0.25%
Beta0.42
IssuerAvantis
Inception DateSep 27, 2022
Dividend Yield1.43%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,741
30 Day Avg. Volume1,292
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
85.14Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering360
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVIE Summary
The Avantis Inflation Focused Equity ETF (AVIE) is a U.S.-focused stock fund that aims to do well when prices in the economy are rising. It doesn’t track a set index, but instead picks companies that may handle inflation better, especially in energy, health care, and consumer staples. Well-known holdings include Berkshire Hathaway, Exxon Mobil, Procter & Gamble, and Coca-Cola. Someone might invest in AVIE to stay in the stock market while trying to protect their money’s buying power and get broad diversification. A key risk is that it can still lose value and move up and down with the overall stock market.
How much will it cost me?The Avantis Inflation Focused Equity ETF (AVIE) has an expense ratio of 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed ETFs because it focuses on inflation-conscious equity investments while maintaining broad market exposure.
What would affect this ETF?The Avantis Inflation Focused Equity ETF (AVIE) could benefit from rising inflation, as its focus on companies with strong pricing power and fundamentals may help it perform well in such environments. Positive trends in sectors like Health Care and Energy, which make up a significant portion of its holdings, could also drive growth. However, economic slowdowns or regulatory changes affecting key sectors like Energy or Financials, as well as declining inflation concerns, could negatively impact its performance.
AVIE Top 10 Holdings
AVIE leans heavily on U.S. health care and energy names, with UnitedHealth and Eli Lilly doing much of the heavy lifting as their shares keep climbing and give the fund a strong defensive backbone. Consumer staples like Procter & Gamble and Coca-Cola add a steady, inflation-friendly cushion, even if PepsiCo has been losing a bit of fizz lately. On the flip side, energy giants Exxon and Chevron have been lagging in the short term, occasionally acting like a headwind for an otherwise resilient, U.S.-focused portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Berkshire Hathaway B | 5.47% | $576.49K | $1.10T | 6.10% | 66 Neutral | |
| Exxon Mobil | 4.39% | $462.53K | $568.16B | 24.08% | 74 Outperform | |
| Eli Lilly & Co | 3.77% | $397.22K | $1.14T | 58.88% | 72 Outperform | |
| Procter & Gamble | 3.73% | $393.13K | $352.57B | -3.26% | 69 Neutral | |
| UnitedHealth | 2.92% | $307.22K | $386.29B | 35.84% | 72 Outperform | |
| Chevron | 2.57% | $271.15K | $336.98B | 13.55% | 71 Outperform | |
| Johnson & Johnson | 2.47% | $260.37K | $633.19B | 71.54% | 78 Outperform | |
| Philip Morris | 2.39% | $251.64K | $284.08B | 5.67% | 61 Neutral | |
| Coca-Cola | 2.18% | $229.38K | $362.01B | 19.66% | 75 Outperform | |
| AbbVie | 1.97% | $207.37K | $461.26B | 34.19% | 66 Neutral |
AVIE Technical Analysis
Positive
―
Price Trends
74.10
Positive
73.20
Positive
69.18
Positive
Market Momentum
0.53
Negative
58.30
Neutral
62.19
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 74.63, equal to the 50-day MA of 74.10, and equal to the 200-day MA of 69.18, indicating a bullish trend. The MACD of 0.53 indicates Negative momentum. The RSI at 58.30 is Neutral, neither overbought nor oversold. The STOCH value of 62.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVIE.
AVIE Peer Comparison
Comparison Results
Performance Comparison
AVIE
Avantis Inflation Focused Equity ETF
75.57
14.93
24.62%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
YALL
God Bless America ETF
―
―
―
RFDA
RiverFront Dynamic US Dividend Advantage ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents